KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Accumulated Expenses (2016 - 2025)

Eli Lilly (LLY) has disclosed Accumulated Expenses for 17 consecutive years, with $2.4 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Expenses rose 13.42% year-over-year to $2.4 billion, compared with a TTM value of $2.4 billion through Dec 2025, up 13.42%, and an annual FY2025 reading of $2.4 billion, up 13.42% over the prior year.
  • Accumulated Expenses was $2.4 billion for Q4 2025 at Eli Lilly, up from $2.0 billion in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $2.4 billion in Q4 2025 and bottomed at $649.9 million in Q1 2021.
  • Average Accumulated Expenses over 5 years is $1.2 billion, with a median of $1.0 billion recorded in 2022.
  • The sharpest move saw Accumulated Expenses fell 3.92% in 2021, then soared 55.73% in 2023.
  • Year by year, Accumulated Expenses stood at $958.1 million in 2021, then increased by 10.61% to $1.1 billion in 2022, then skyrocketed by 55.73% to $1.7 billion in 2023, then rose by 26.88% to $2.1 billion in 2024, then increased by 13.42% to $2.4 billion in 2025.
  • Business Quant data shows Accumulated Expenses for LLY at $2.4 billion in Q4 2025, $2.0 billion in Q3 2025, and $1.3 billion in Q2 2025.